CD19 and B-cell non-Hodgkin lymphoma: CD19 expression covers the entire spectrum of early B-cell genesis and maturation, and its potential has been shown clinically for the treatment of B-cell lymphomas [26], as well as in the treatment of autoimmune diseases.